Serial Casting for Burns Contracture
Trial Summary
What is the purpose of this trial?
The use of a splint, serial casting and passive stretching have been described in the literature as conservative interventions to manage joint contractures after burn injury. There is a paucity of literature investigating the effect of serial casting on scar contractures following upper extremity (UE) burn injury in adults and a lack of studies using strong methodological approaches. There are also no studies investigating the effect of casting on hypertrophic scars (HSc) and on self-reported UE function. This study is a longitudinal case series design with a criteria for change on the use of serial casting for the treatment of upper extremity burn contractures. The purpose of this study is to estimate the extent to which range of motion (AROM and PROM), scar characteristics and patient-reported upper-extremity function changes following an individually-tailored serial casting treatment program after switching from one week of usual care and to determine if these changes can be maintained 3 weeks after stopping serial casting, for adult burn survivors who developed an upper-extremity joint contracture greater than 15% normal range of motion within 1-year post-burn. This study will be a longitudinal case series design with a criteria for change. A minimum of 12 participants will be recruited from the "Centre d'expertise pour les victimes de brûlures graves de l'ouest du Québec" (CEVBGOQ) and will undergo one week of "usual care". If the PROM of the joint does not improve after one week of usual care, the participant will start the serial casting process, which will be prescribed by the treating OT. PROM/AROM and scar characteristics will be measured using a revised goniometry protocol that incorporates cutaneokinematics (CKM) principles and precise skin measures (DermaScan C, Cutometer®, Mexameter® and Tewameter®) at baseline, every Monday and Friday of the treatment weeks and 3 weeks after treatment cessation. Self-reported UE function and satisfaction related to scarring will be assessed at baseline and 3 weeks after treatment cessation using the QuickDASH and the patient satisfaction assessment scale (PSAS). Analysis on ROM and scar characteristic will be conducted using a graphical representation with a projected "usual care" regression line to count how many outcomes were over the line once the treatment was introduced. This study will contribute to building evidence for the use of serial casting following UE burn contractures in the adult population.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Tailored serial casting intervention for burns contracture?
Research shows that serial casting can effectively improve movement in joints affected by burn contractures, with studies reporting significant increases in range of motion and improvements in scar appearance. It is a simple, cost-effective method that can work even when other treatments fail, and it may reduce the need for surgery.12345
How does the treatment of serial casting for burn contractures differ from other treatments?
Serial casting is unique because it provides continuous pressure and stretch to the contracted tissue, which helps increase the range of motion and can be effective even when traditional methods like massage, exercise, and splinting fail. It is a non-surgical option that can be particularly useful for patients who are noncompliant or when other devices cannot be sized appropriately, offering immediate results with minimal complications.12346
Research Team
Bernadette Nedelec, PhD
Principal Investigator
CRCHUM
Eligibility Criteria
This trial is for adult burn survivors who have lost more than 15% of their normal range of motion in joints like fingers, wrists, or elbows due to fire, flame, or scald burns. They must understand English or French and be able to follow the study's procedures. People with frostbite, chemical/electrical burns, certain psychiatric/cognitive disorders, neurological injuries from the burn, pre-existing conditions affecting movement, heterotopic ossification or when stretching is not advised cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Usual Care
Participants receive one week of usual care to assess improvement in PROM
Serial Casting Treatment
Participants undergo tailored serial casting intervention if no improvement in PROM is observed
Follow-up
Participants are monitored for changes in ROM, scar characteristics, and self-reported function 3 weeks after treatment cessation
Treatment Details
Interventions
- Tailored serial casting intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor